Women who do not undergo adjuvant treatment for breast cancers are typically older and less likely to hold knowledge and beliefs about these treatments

Author：  

Publisher： Adis International

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.590, 2009-01, pp. : 9-9

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Value of Adjuvant Treatment in Young Women with Breast Cancer

By Clive S.  

Drugs, Vol. 62, Iss. 1, 2002-01 ,pp. : 1-11

Adis International

Access to resources Recommend Favorite

Older patients and Black patients are less likely to receive intensive treatment for locoregional oesophageal cancer than younger, White patients

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 534, 2007-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Taxanes in the Adjuvant Treatment of Breast Cancer

By Trauth Donna   Goldstein Lori J.  

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 1, Iss. 2, 2003-04 ,pp. : 222-231

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite

Role of Adjuvant Therapy in Older People with Breast Cancer

By  

JOURNAL OF PHARMACY PRACTICE AND RESEARCH, Vol. 37, Iss. 4, 2007-12 ,pp. : 321-324

John Wiley & Sons Inc

Access to resources Recommend Favorite

Aromatase Inhibitors: A New Reality for the Adjuvant Endocrine Treatment of Early-Stage Breast Cancer in Postmenopausal Women

By  

Mini Reviews in Medicinal Chemistry, Vol. 8, Iss. 6, 2008-06 ,pp. : 564-574

Bentham Science Publishers

Access to resources Recommend Favorite